The status of PET radiochemistry for drug development and evaluation

Drug Information Journal

Volumn 31, Issue 3, 1997, Pages 997-1013

  Pike, Victor William ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Carbon 11; Drugs; Fluorine 18; PET; Radiochemistry

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMINE OXIDASE (FLAVIN CONTAINING); BENZODIAZEPINE; BROMINE; CARBON 11; COBALT; COPPER 62; DOPAMINE; ENZYME; FLUMAZENIL; FLUORINE 18; GALLIUM 68; IODINE; IRON 52; LEVODOPA; METHANE; NITROGEN 13; OPIATE; OXYGEN 15; POTASSIUM; RADIOISOTOPE; RADIOLIGAND; RECEPTOR; RUBIDIUM 82; SELENIUM; SEROTONIN; SPIPERONE; TECHNETIUM; TRACER; UNINDEXED DRUG;

ARTICLE; AUTOMATION; BINDING SITE; BLOOD FLOW; CYCLOTRON; DRUG DEVELOPMENT; DRUG HALF LIFE; ENZYME LOCALIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; METABOLITE; PHARMACODYNAMICS; PHARMACOKINETICS; POSITRON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNTHESIS;

EID: 0030872189     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159703100344     Document Type: Article

References (59)

1. Comar D, Ed. PET for Drug Development and Evaluation. Kluwer Academic Publishers (Dordrecht). Dev Nucl Med. 1995;26.
2. Pike VW. Positron-emitting Radioligands for Studies In Vivo - Probes for Human Psychopharmacology. J Psychopharmacol. 1993;7:139-158.
3. Qaim S, Clark JC, Crouzel C, Guillaume M, Helmeke HJ, Nebeling B, Pike VW, Stöcklin G. PET Radionuclide Production. In Radiopharmaceuticals for Positron Emission Tomography. Methodological Aspects. Stöcklin G, Pike VW, Eds. Kluwer Academic Press (Dordrecht). Dev Nucl Med. 1993;24: 1-43.
4. 2 production. App Radiat Isot. 1995;46:87-91.
5. Bergman J, Kallman KM, Solin O, DeJesus OT, Oakes TR, Nickles RJ. A New Method for the Production of Electrophilic F-18 Starting from Aqueous [F-18]Fluoride. J Nucl Med. 1993;34:P69.
6. 18F]WIN 35428). J Label Compd Radiopharm. 1995;37:46-48.
7. Lambrecht RM, Sajjad M, Bakr S. I-124 - A Unique Dual Label for Diagnostic (PET) and Therapeutic Radiopharmaceuticals. J Nucl Med. 1988;29:1324.
8. Zweit J, Luthra SK, Brady F, Carnochan P, Ott RJ, Jones T. Iodine-120, a New Positron Emitting Radionuclide for PET Radiopharmaceuticals. J Label Compd Radiopharm. 1995;37:823-825.
9. 94mTc from Enriched Molybdenum Targets and its Large Scale Production for Nuclear Medicine Application. Radiochim Acta. 1994;64:113-120.
10. 94mTc for PET Imaging. App Radiat Isot. 1995;46:69-73.
11. 18F]Fluoro-L-dopa. App Radiat Isot. 1992;43:989-996.
12. 18F]-Fluoro-2-deoxy-D-glucose using Aminopolyether Supported Nucleophilic Substitution. J Nucl Med. 1986;27:235-238.
13. 18F]Fluoro Amino acid Synthesis. J Label Compd Radiopharm. 1994;34:163-164.
14. 18F]fluoro-2-deoxy-D-glucose. J Label Compd Radiopharm. 1995;37:743-744.
15. 18F]Fluoroethyl)-spiperone, a Potent Dopamine Antagonist; Synthesis, Structural Analysis and In-Vivo Utilization in Humans. App Radiat Isot. 1990;41:113-129.
16. 18F]fluoride. J Nucl Med. 1994;35:1996-2002.
17. 18F]Fluoroarenes. J Chem Soc Chem Comm. 1995; 2215-2216.
18. 11C]Acetate - An Agent for the Study of Myocardial Metabolism by Positron Emission Tomography. Int J App Radiat Isot. 1982;33:505-512.
19. 11C]Methyl Iodide. App Radiat Isot. 1987;38:601-603.
20. 11C-Labelled Methyl Iodide from Methane. J Label Compd Radiopharm. 1995;37: 73-75.
21. 11C]Methyl Triflate. App Radiat Isot. 1992;43:1383-1385.
22. 11C]β-CFT. Nucl Med Biol. 1995;22:965-970.
23. 3]Methyl Nonaflate) Using a Solid State Support. J Label Compd Radiopharm. 1995;37:98-99.
24. 18F]-Fluoride. J Label Compd Radiopharm. 1995;37:736-738.
25. Stone-Elander S, Elander N. Fast Chemistry in Microwave Fields - Nucleophilic [F-18]Radiofluorinations of Aromatic Molecules. App Radiat Isot. 1993; 44:889-893.
26. 3/MF: a Useful Method for Rapid Labelling. J Label Compd Radiopharm. 1994;35:94-96.
27. 3/KF in a Disposable Unit. J Label Compd Radiopharm. 1995;37:755-757.
28. 11CN for Medical Use and Radiopharmaceutical Syntheses, IX. J Nucl Med. 1973;14:864.
29. 11C]Nitroalkanes. App Radiat Isot. 1989;40:261-262.
30. 11C-Labeled Phosgene. App Radiat Isot. 1987;38:297-300.
31. 11C]thymidine. J Label Compd Radiopharm. 1994;35:178-180.
32. 11C-methyl-]Methylisocyanate and Application with Microwave Heating to Labelling the Novel Anticancer Agent Temozolamide. J Label Compd Radiopharm. 1994; 35:100-102.
33. Luthra SK, Pike VW, Brady F. The Preparation of Carbon-11 Labelled Diprenorphine: a New Radioligand for the Study of the Opiate Receptor System in Vivo. J Chem Soc Chem Comm. 1985;1423-1425.
34. 11C]Acid Chlorides as Labelling Agents. App Radiat Isot. 1990;41:471-476.
35. 1-Adrenoreceptor Antagonist. J Label Compd Radiopharm. 1988;25:177-183.
36. 11C]Phosgene. J Label Compd Radiopharm. 1994;35:324-326.
37. 11C]Aniline. J Label Compd Radiopharm. 1995;36:33-41.
38. 11C-Labelled Aromatic Compounds. J Label Compd Radiopharm. 1995;37:613-615.
39. Bjurling P, Reineck R, Westerberg G, Schultz J, Gee A, Sutcliffe J, Långström B. Synthia, a Compact Radiochemistry System for Automated Production of Radiopharmaceuticals. Proceedings of the 6th Workshop on Targetry and Target Chemistry. Vancouver BC, August 1995.
40. Crouzel C, Clark JC, Brihaye C, Långström B, Lemaire C, Meyer G-J, Nebeling B, Stone-Elander S. Radiochemistry Automation for PET. In: Radiopharmaceuticals for Positron Emission Tomography -Methodological Aspects. Stöcklin G, Pike VW, Eds. Kluwer Academic Publishers (Dordrecht). Dev Nucl Med. 1993;24:91-150.
41. Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilboum MA. Routine Production of [F-18]Fluorodeoxyglucose by Direct Nucleophilic Exchange on a Quaternary Ammonium Resin. Nucl Med Biol. 1990;17:273-279.
42. 18F]FDG) via the GE Microlab Device; The Washington University Experience. J Label Compd Radiopharm. 1995;37:653-654.
43. Meyer G-J, Coenen HH, Waters SL, Långström B, Cantineau R, Strijkmans K, Vaalburg W, Halldin C, Crouzel C, Mazière B, Luxen A. Quality Assurance and Quality Control of Short-Lived Radiopharmaceuticals for PET. In: Radiopharmaceuticals for Positron Emission Tomography - Methodological Aspects. Stöcklin G, Pike VW, Eds. Kluwer Academic Publishers (Dordrecht). Dev Nucl Med. 1993;24: 151-178.
44. Meyer G-J, Waters SL, Coenen HH, Luxen A, Mazière B, Langström B. PET Radiopharmaceuticals in Europe; Current Use and Data Relevant for the Formulation of Summaries of Product Characteristics (SPCs). Eur J Nucl Med. 1995;22:1420-1432.
45. FDA (Center for Drug Evaluation and Research). Draft Guideline on the Manufacture of Positron Emission Tomographic (PET) Drug Products. December 1994.
46. United States Pharmacopeial Convention. The Development of a USP General Chapter for the Preparation of PET Radiopharmaceuticals for Human Use. Pharmacopeial Forum. 1996;22(1).
47. 11C-Labelled Products. J Label Compd Radiopharm. 1987;25:1070-1072.
48. Pike VW, Waters SL, Aigbirhio H, Makepeace J, Tanner RJN. Novel Use of an Isotope Separator to Determine the Position of Fluorine-18 in Labelled 1,1,1,2-Tetrafluoroethanes. Org Mass Spectrom. 1994;29:499-504.
49. Pike VW, Aigbirhio FI, Freemantle CAJ, Page BC, Rhodes CGR, Waters SL, Jones T, Olsson P, Ventresca GP, Tanner RJN, Hayes M, Hughes JMB. The Disposition of Inhaled HFA134a (1,1,1,2-Tetrafluoroethane) in Healthy Subjects and Patients with Chronic Airflow Impairment - Measurement by Fluorine-18 Labelling and Whole-body γ-counting. Drug Metab Disposition. 1995;23:832-839.
50. Aigbirhio FI, Pike VW, Carr RM, Sutherland DR, Roche T, Daniel MJ, Waters SL. Labelling of Fluticasone Propionate Particles in a Metered-Dose Inhaler with Fluorine-18 for PET Studies of Inhaled Drug Deposition. Accepted for presentation at the 43rd Annual Meeting of the Society of Nuclear Medicine, Denver, June 1996. J Nucl Med. 1997.
51. Cunningham VJ, Lammertsma AA. Radioligand studies in brain: kinetic analysis of PET data. Med Chem Res. 1995;5:79-96.
52. Mazière B, Cantineau R, Coenen HH, Guillaume M, Halldin C, Luxen A, Loc'h C, Luthra SK. PET Radiopharmaceutical Metabolism - Plasma Metabolite Analysis. In: Radiopharmaceuticals for Positron Emission Tomography - Methodological Aspects. Stöcklin G, Pike VW, Eds. Kluwer Academic Publishers (Dordrecht). Dev. Nucl Med. 1993;24: 151-178.
53. 11C]Scherring 23390. J Label Compd Radiopharm. 1993;32:518-520.
54. 11C]WAY-100635. Eur J Pharmacol. 1995;283:R1-R3.
55. 11C]WAY-100635, in Monkey and Human Plasma by HPLC - Comparison of the Behaviour of an Identified Radioactive Metabolite with Parent Radioligand in Monkey using PET. Nucl Med Biol. 1996;23:627-634.
56. 11C]WAY-100635. Med Chem Res. 1995;5:208-227.
57. 11C]WAY-100635. Eur J Pharmacol. 1996;301:R5-R7.
58. Bench CJ, Price GW, Lammertsma AA, Cremer JE, Luthra SK, Turton D, Dolan RJ, Kettler R, Dingemanse J, Da Prada M, Bizière K, McClelland GR, Jamieson VL, Wood ND, Frackowiak RSJ. Measurement of Human Cerebral Monoamine Oxidase Type B (MOA-B) Activity with Positron Emission Tomography (PET). A Dose Ranging Study with the Reversible Inhibitor RO 19-6327. Eur J Clin Pharmacol. 1991;40:169-183.
59. 11C]Raclopride. Psychopharmacol. 1993;112:308-314.